208 related articles for article (PubMed ID: 32425939)
1. Pharmacological Inhibition of MALT1 Protease Leads to a Progressive IPEX-Like Pathology.
Martin K; Junker U; Tritto E; Sutter E; Rubic-Schneider T; Morgan H; Niwa S; Li J; Schlapbach A; Walker D; Bigaud M; Beerli C; Littlewood-Evans A; Rudolph B; Laisney M; Ledieu D; Beltz K; Quancard J; Bornancin F; Zamurovic Ribrioux N; Calzascia T
Front Immunol; 2020; 11():745. PubMed ID: 32425939
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological Inhibition of MALT1 Ameliorates Autoimmune Pathogenesis and Can Be Uncoupled From Effects on Regulatory T-Cells.
Biswas S; Chalishazar A; Helou Y; DiSpirito J; DeChristopher B; Chatterjee D; Merselis L; Vincent B; Monroe JG; Rabah D; Long AJ
Front Immunol; 2022; 13():875320. PubMed ID: 35615349
[TBL] [Abstract][Full Text] [Related]
3. Malt1 Protease Deficiency in Mice Disrupts Immune Homeostasis at Environmental Barriers and Drives Systemic T Cell-Mediated Autoimmunity.
Martin K; Touil R; Kolb Y; Cvijetic G; Murakami K; Israel L; Duraes F; Buffet D; Glück A; Niwa S; Bigaud M; Junt T; Zamurovic N; Smith P; McCoy KD; Ohashi PS; Bornancin F; Calzascia T
J Immunol; 2019 Dec; 203(11):2791-2806. PubMed ID: 31659015
[TBL] [Abstract][Full Text] [Related]
4. A MALT1 inhibitor suppresses human myeloid DC, effector T-cell and B-cell responses and retains Th1/regulatory T-cell homeostasis.
Dumont C; Sivars U; Andreasson T; Odqvist L; Mattsson J; DeMicco A; Pardali K; Johansson G; Yrlid L; Cox RJ; Seeliger F; Larsson M; Gehrmann U; Davis AM; Vaarala O
PLoS One; 2020; 15(9):e0222548. PubMed ID: 32870913
[TBL] [Abstract][Full Text] [Related]
5. Deficiency in Mucosa-associated Lymphoid Tissue Lymphoma Translocation 1: A Novel Cause of IPEX-Like Syndrome.
Charbit-Henrion F; Jeverica AK; Bègue B; Markelj G; Parlato M; Avčin SL; Callebaut I; Bras M; Parisot M; Jazbec J; Homan M; Ihan A; Rieux-Laucat F; Stolzenberg MC; Ruemmele FM; Avčin T; Cerf-Bensussan N;
J Pediatr Gastroenterol Nutr; 2017 Mar; 64(3):378-384. PubMed ID: 27253662
[TBL] [Abstract][Full Text] [Related]
6. MALT1 Proteolytic Activity Suppresses Autoimmunity in a T Cell Intrinsic Manner.
Demeyer A; Skordos I; Driege Y; Kreike M; Hochepied T; Baens M; Staal J; Beyaert R
Front Immunol; 2019; 10():1898. PubMed ID: 31474984
[TBL] [Abstract][Full Text] [Related]
7. Treatment with rapamycin can restore regulatory T-cell function in IPEX patients.
Passerini L; Barzaghi F; Curto R; Sartirana C; Barera G; Tucci F; Albarello L; Mariani A; Testoni PA; Bazzigaluppi E; Bosi E; Lampasona V; Neth O; Zama D; Hoenig M; Schulz A; Seidel MG; Rabbone I; Olek S; Roncarolo MG; Cicalese MP; Aiuti A; Bacchetta R
J Allergy Clin Immunol; 2020 Apr; 145(4):1262-1271.e13. PubMed ID: 31874182
[TBL] [Abstract][Full Text] [Related]
8. In situ conversion of defective Treg into SuperTreg cells to treat advanced IPEX-like disorders in mice.
Li Y; Chen Y; Mao S; Kaundal R; Jing Z; Chen Q; Wang X; Xia J; Liu D; Sun J; Wang H; Chi T
Nat Commun; 2020 Jun; 11(1):2781. PubMed ID: 32493900
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of MALT1 Decreases Neuroinflammation and Pathogenicity of Virulent Rabies Virus in Mice.
Kip E; Staal J; Tima HG; Verstrepen L; Romano M; Lemeire K; Suin V; Hamouda A; Baens M; Libert C; Kalai M; Van Gucht S; Beyaert R
J Virol; 2018 Nov; 92(22):. PubMed ID: 30158289
[TBL] [Abstract][Full Text] [Related]
10. A patent review of MALT1 inhibitors (2013-present).
Hamp I; O'Neill TJ; Plettenburg O; Krappmann D
Expert Opin Ther Pat; 2021 Dec; 31(12):1079-1096. PubMed ID: 34214002
[TBL] [Abstract][Full Text] [Related]
11. DOCK8 Deficiency Presenting as an IPEX-Like Disorder.
Alroqi FJ; Charbonnier LM; Keles S; Ghandour F; Mouawad P; Sabouneh R; Mohammed R; Almutairi A; Chou J; Massaad MJ; Geha RS; Baz Z; Chatila TA
J Clin Immunol; 2017 Nov; 37(8):811-819. PubMed ID: 29058101
[TBL] [Abstract][Full Text] [Related]
12. Normal lymphocyte homeostasis and function in MALT1 protease-resistant HOIL-1 knock-in mice.
Skordos I; Driege Y; Haegman M; Kreike M; Staal J; Demeyer A; Beyaert R
FEBS J; 2023 Apr; 290(8):2032-2048. PubMed ID: 36479846
[TBL] [Abstract][Full Text] [Related]
13. Quantitative analysis of tissue inflammation and responses to treatment in immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome, and review of literature.
Chen CA; Chung WC; Chiou YY; Yang YJ; Lin YC; Ochs HD; Shieh CC
J Microbiol Immunol Infect; 2016 Oct; 49(5):775-782. PubMed ID: 26748735
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological inhibition of MALT1 protease activity suppresses endothelial activation via enhancing MCPIP1 expression.
Li Y; Huang S; Huang X; Li X; Falcon A; Soutar A; Bornancin F; Jiang Z; Xin HB; Fu M
Cell Signal; 2018 Oct; 50():1-8. PubMed ID: 29913212
[TBL] [Abstract][Full Text] [Related]
15. Malt1 Protease Is Critical in Maintaining Function of Regulatory T Cells and May Be a Therapeutic Target for Antitumor Immunity.
Cheng L; Deng N; Yang N; Zhao X; Lin X
J Immunol; 2019 May; 202(10):3008-3019. PubMed ID: 30979818
[TBL] [Abstract][Full Text] [Related]
16. IPEX due to an exon 7 skipping FOXP3 mutation with autoimmune diabetes mellitus cured by selective T
Magg T; Wiebking V; Conca R; Krebs S; Arens S; Schmid I; Klein C; Albert MH; Hauck F
Clin Immunol; 2018 Jun; 191():52-58. PubMed ID: 29567430
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological inhibition of MALT1 protease activity protects mice in a mouse model of multiple sclerosis.
Mc Guire C; Elton L; Wieghofer P; Staal J; Voet S; Demeyer A; Nagel D; Krappmann D; Prinz M; Beyaert R; van Loo G
J Neuroinflammation; 2014 Jul; 11():124. PubMed ID: 25043939
[TBL] [Abstract][Full Text] [Related]
18. Lentiviral Gene Therapy in HSCs Restores Lineage-Specific Foxp3 Expression and Suppresses Autoimmunity in a Mouse Model of IPEX Syndrome.
Masiuk KE; Laborada J; Roncarolo MG; Hollis RP; Kohn DB
Cell Stem Cell; 2019 Feb; 24(2):309-317.e7. PubMed ID: 30639036
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic Potential of Targeting Malt1-Dependent TCR Downstream Signaling to Promote the Survival of MHC-Mismatched Allografts.
Govender L; Mikulic J; Wyss JC; Gaide O; Thome M; Golshayan D
Front Immunol; 2020; 11():576651. PubMed ID: 33042160
[TBL] [Abstract][Full Text] [Related]
20. MALT1 is an intrinsic regulator of regulatory T cells.
Brüstle A; Brenner D; Knobbe-Thomsen CB; Cox M; Lang PA; Lang KS; Mak TW
Cell Death Differ; 2017 Jul; 24(7):1214-1223. PubMed ID: 26405015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
